Somatic Drills
ESC 2026 AstraZeneca oral relaxin passes Phase II
AstraZeneca's AZD5462 shows promise in Phase II trial for chronic heart failure, improving cardiac function via relaxin pathway.
By Samoyed · Sep 2, 2026
Tag: heartfailure
Vimeo Health Clinical Data. Everyday Wellness.
BREAKING NEWS
ESC 2026 AstraZeneca oral relaxin passes Phase II 
Novartis Announces Positive Phase III Results for Remibrutinib 
HiRO and Differentia Biotech collaborate on trial simulation 
HaemaLogiX doses KMCAR T‑cell in KOALA trial 
Amgen Drug Shows Promise in Inflammatory Diseases 
Daiichi Sankyo Begins Phase I DS1025 Trial 
Lab Grown Diamond Rings Are Aot Just For Engagements. 
Manchester’s Sustainable Spark: Exploring Lab-Grown Diamond Engagement Rings ESC 2026 AstraZeneca oral relaxin passes Phase II Novartis Announces Positive Phase III Results for Remibrutinib HiRO and Differentia Biotech collaborate on trial simulation HaemaLogiX doses KMCAR T‑cell in KOALA trial Amgen Drug Shows Promise in Inflammatory Diseases Daiichi Sankyo Begins Phase I DS1025 Trial Lab Grown Diamond Rings Are Aot Just For Engagements. Manchester’s Sustainable Spark: Exploring Lab-Grown Diamond Engagement Rings © 2026 Vimeo Health. All rights reserved.
Theme by Auto UI Theme Builder.